Kronostar 300 Tablet CR is a controlled-release formulation containing Sodium Valproate 200 mg and Valproic Acid 87 mg, indicated primarily for the management of epilepsy and bipolar disorder. The combination of these active ingredients acts as an anticonvulsant and mood stabilizer by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, thereby exerting an inhibitory effect on neuronal excitability. This dual mechanism helps in the prevention of various seizure types including absence seizures, complex partial seizures, and generalized tonic-clonic seizures. Additionally, Kronostar 300 Tablet CR is effective in stabilizing mood swings in patients with bipolar affective disorder, reducing the frequency and severity of manic episodes. The controlled-release formulation ensures a steady plasma concentration, minimizing peak-related side effects and enhancing patient compliance through once or twice-daily dosing. Common adverse effects may include gastrointestinal disturbances, tremors, weight gain, and sedation. Liver function tests and blood counts should be monitored regularly due to the risk of hepatotoxicity and hematological abnormalities. This medication should be used under strict medical supervision, with caution advised in pregnant women due to potential teratogenicity. Kronostar 300 Tablet CR offers a reliable therapeutic option for long-term management of seizure disorders and mood stabilization.